Senators push FDA to approve drug for rare disease

Published



Two Republican senators want the Food and Drug Administration to approve a new drug to treat a rare, fatal disease despite concerns about whether it actually works.

Sens. Ron Johnson, R-Wis., and Dan Coats, R-Ind., are disappointed that a panel of experts did not recommend a new drug called Sarepta for Duchenne muscular dystrophy, a fatal disease that mainly affects young boys. The senators’ call follows a massive online grassroots effort to get the agency to approve the drug despite questions about its safety.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.